Introduction {#Sec1}
============

Coronaviruses are remarkably large, positive-stranded RNA viruses that are enveloped with the nucleocapsid having helical symmetry. The *corona in coronavirus* is a Latin word that means a "crown", and it indicates to the typical presentation of [virions](https://en.wikipedia.org/wiki/Virion) underneath electron microscopy with a periphery of hefty, globular surface projections similar to that of a crown. Coronavirus is a pathogen associated with severe respiratory symptoms and was first identified from the nasal cavities of sufferers with the common cold in the early 1960s (de Groot et al. [@CR12]; Brown et al. [@CR6]). These were named human coronavirus OC43 and human coronavirus 229E. A total of 40 sequenced genomes of different strains of coronavirus are accessible from National Center for Biotechnology Information (NCBI), out of which 7 are pathogenic to humans. A coronavirus, i.e. SARS-CoV, was responsible for outbreak of severe acute respiratory syndrome (SARS) in the year 2003, whereas Middle East respiratory syndrome coronavirus (MERS-CoV) caused the most recent outbreak in 2012 causing acute respiratory disease in affected people with signs of fever, cough and difficulty in breathing. After first reported from Saudi Arabia in 2012, this novel virus has also dispersed to other countries like the United States and was known to have high death rate. MERS-CoV infections are highly communicable, and no explicit antiviral cure has been designed for it till date (Azhar et al. [@CR3]).

It compelled us to apply the well-known reverse vaccinology (RV) approach on available proteome of coronavirus. RV approach has been successfully applied on many prokaryotes, but there are very few known applications on eukaryotes and viruses. So, it is worthwhile to explore the potential of this approach to identify potential vaccine candidates for coronavirus. RV basically does the in silico examination of the viral proteome to hunt antigenic and surface-exposed proteins. This approach was initially applied successfully to *Neisseria meningitidis* serogroup B (Kelly and Rappuoli [@CR24]) against which none of the prevailing techniques could develop a vaccine. The present book chapter is intended to explore the potential of RV approach to select the probable vaccine candidates against coronavirus and validate the results using docking studies.

The Elementary Concept of Reverse Vaccinology {#Sec2}
=============================================

Undoubtedly, the traditional approaches for vaccine development are fortunate enough to efficiently resist the alarming pathogenic diseases of its time. However, the traditional approach suffers from certain limitations like it is very time-consuming, the pathogens which can't be cultivated in the lab conditions are out of reach, and certain non-abundant proteins are not accessible using this approach (Rappuoli [@CR39]). Consequently, a number of pathogenic diseases are left without any vaccine against them. All these limitations are conquered by reverse vaccinology approach utilizing genome sequence information which ultimately is translated into proteins. Hence all the proteins expressed by the genome are accessible irrespective of their abundance, conditions in which they expressed. The credit of fame of reverse vaccinology should go to the advancements in the sequencing strategies worldwide. Accordingly, improvement in the sequencing technologies has flooded the genome databases with huge amount of data which can be computationally undertaken to reveal the various crucial aspects of the virulence factors of the concerned pathogen. Reverse vaccinology is based on same approach of computationally analysing the genome of pathogen and proceeds step by step to ultimately identify the highly antigenic, secreted proteins with high epitope densities. The best epitopes are selected as potential vaccine candidates (Pizza et al. [@CR38]). This approach has brought the unapproachable pathogens of interest in spotlight and is evolving as the most reassuring tool for precise selection of vaccine candidates and brought the use of peptide vaccines in trend (Sette and Rappuoli [@CR43]; Kanampalliwar et al. [@CR22]).

Successful Applications of Reverse Vaccinology {#Sec3}
==============================================

Bexsero is the first universal serogroup B meningococcal vaccine developed using RV, and it has currently earned positive judgement from the European Medicines Agency (Gabutti [@CR16]). Whether it is discovery of pili in gram-positive pathogens which were thought to not have any pili or the sighting of factor G-binding protein in meningococcus (Alessandro and Rino [@CR1]), the reverse vaccinology steals all the credits from other conventional approaches. Most of the applications of RV are against prokaryotes and very few against eukaryotes and viruses because of complexity of their genome. *Corynebacterium urealyticum* (Guimarães et al. [@CR20]), *Mycobacterium tuberculosis* (Monterrubio-López et al. [@CR32]), [*H. pylori*](http://www.ncbi.nlm.nih.gov/pubmed/25818402) (Naz et al. [@CR33]), [*Acinetobacter baumannii*](http://www.ncbi.nlm.nih.gov/pubmed/25751377) (Chiang et al. [@CR9]), *Rickettsia prowazekii* (Caro-Gomez et al. [@CR8]), *Neospora caninum* (Goodswen et al. [@CR19]) and *Brucella melitensis* (Vishnu et al. [@CR46]) are the examples of some pathogens that are recently approached using this in silico technique in order to spot some epitopes having potential of being a vaccine candidate. *Herpesviridae* (Bruno et al. [@CR7]) and hepatitis C virus (HCV) (Kolesanova et al. [@CR25]) are the examples of the viruses that are addressed using this approach.

Workflow of Reverse Vaccinology (with Example of Coronavirus) {#Sec4}
=============================================================

Retrieval of Proteome of Different Strains of Coronavirus from NCBI {#Sec5}
-------------------------------------------------------------------

The proteome of different strains of the coronavirus of interest was downloaded from NCBI's ftp site (<ftp://ftp.ncbi.nlm.nih.gov/genomes/Viruses/>; NCBI Resource Coordinators [@CR34]). The proteome information is available for download in many formats including FASTA format for different sequenced viruses. Strains pathogenic to humans were selected for further analysis. Among them a single strain was selected as the seed genome on the basis of literature. Sequence similarity searches using Blastp (<http://blast.ncbi.nlm.nih.gov/blast>, <http://ugene.unipro.ru>/) were performed to reveal the orthologs in different strains (Altschul et al. [@CR2]; Okonechnikov et al. [@CR35]; Golosova et al. [@CR18]). Multiple sequence alignment (MSA) was done via ClustalW, and the phylogenetic tree was constructed using NJ method from Unipro UGENE 1.16.1 bioinformatics toolkit (Okonechnikov et al. [@CR35]).

Analysis of Secondary Structure of Proteins from Seed Genome {#Sec6}
------------------------------------------------------------

Analysis of secondary structure of the proteins of seed genome was done by means of ExPASy portal. The aim is to forecast the solvent accessibility, instability index, theoretical pI, molecular weight, grand average of hydropathicity (GRAVY), aliphatic index, number of charged residues, extinction coefficient etc. (<http://web.expasy.org/protparam/>; Gasteiger et al. [@CR17]).

Subcellular Localization Predictions and Count of Transmembrane Helices {#Sec7}
-----------------------------------------------------------------------

Virus-mPLoc was used to identify the localization of proteins of virus in the infected cells of host (<http://www.csbio.sjtu.edu.cn/bioinf/virus-multi/>; Hong-Bin Shen and Kuo-Chin Chou [@CR44]). This information is important to understand the destructive role and mechanism of the viral proteins in causing the disease. In total six different subcellular locations, namely, host cytoplasm, viral capsid, host plasma membrane, host nucleus, host endoplasmic reticulum and secreted proteins, were covered. These predictions could help in formulation of better therapeutic options against the virus. As per the protocol of RV, secreted and membrane proteins are of special interest, therefore, filtered for further analysis. To predict the number of transmembrane helices TMHMM Server *v. 2.0* (<http://www.cbs.dtu.dk/services/TMHMM/>; Krogh et al. [@CR28]) was used.

Signal Peptides {#Sec8}
---------------

Signal peptides are known to impact the immune responses and possess high epitope densities. Moreover, most of the known vaccine candidates also possess signal peptides. Hence, it is worthwhile to predict signal peptides in proteins prior to epitope predictions. Signal-BLAST web server is used to predict the signal peptides without any false predictions (<http://sigpep.services.came.sbg.ac.at/signalblast.html>; Frank and Sippl [@CR15]). The prediction options include best sensitivity, balanced prediction, best specificity and detect cleavage site only. We choose to make the predictions using each option, and the proteins predicted as signal peptide by all the four options were preferred for further investigation.

Adhesion Probability {#Sec9}
--------------------

The most appropriate targets as vaccine candidates are those which possess the adhesion-like properties because they not only mediate the adhesion of pathogen's proteins with cells of host but also facilitate transmission of virus. Adhesions are known to be crucial for virulence and are located on surface which makes them promptly approachable to antibodies. The stand-alone SPAAN with a sensitivity of 89% and specificity of 100% was used to carry out the adhesion probability predictions, and the proteins with having adhesion probabilities higher than or equal to 0.4 were selected (Sachdeva et al. [@CR40]).

BetaWrap Motifs {#Sec10}
---------------

BetaWrap motifs are dominant in virulence factors of the pathogens. If the proteins are predicted to possess such motifs, then they are appropriate to be taken under reverse vaccinology studies. BetaWrap server is the only online web server to make such predictions. The proteins having P-value lower than 0.1 were anticipated to contain BetaWraps (<http://groups.csail.mit.edu/cb/betawrap/betawrap.html>; Bradley et al. [@CR5]).

Antigenicity Predictions {#Sec11}
------------------------

For added identification of the antigenic likely of the proteins, they were subjected to VaxiJen server *version 2.0.* It is basically an empirical method to hunt antigenic proteins. So, if the proteins are not found antigenic using other sequence-based methods, then they can be identified using this method. This step confirms the antigenicity of proteins selected using above-mentioned steps (<http://www.ddg-pharmfac.net/vaxijen/VaxiJen/VaxiJen.html>; Doytchinova and Flower [@CR14]).

Allergenicity Predictions {#Sec12}
-------------------------

For being a probable vaccine candidate, the protein should not exhibit the characteristics of an allergen as they trigger the type-1 hypersensitivity reactions causing allergy. Therefore, to escape out such possibilities, the proteins were also subjected to allergenicity predictions using Allertop (<http://www.pharmfac.net/allertop>; Dimitrov et al. [@CR13]) and AlgPred tools (<http://www.imtech.res.in/raghava/algpred/submission.html>; Saha and Raghava [@CR41], [@CR42]).

Similarity with Host Proteins {#Sec13}
-----------------------------

To check whether the filtered proteins possess any similarity to host proteins or not, the standard Blastp (<http://blast.ncbi.nlm.nih.gov/blast>) searches were performed. In case of sequence similarity, there is a feasibility of generation of immune responses against own cells.

Epitope Mapping {#Sec14}
---------------

Predicting the epitopes binding to MHC class I is the main decisive phase of the RV to carry out valid vaccine predictions. The epitopes showing their affinity for T-cells were first selected via IEDB (<http://tools.immuneepitope.org/mhci/>), ProPred-I (<http://www.imtech.res.in/raghava/propred1/>; Singh and Raghava [@CR45]), BIMAS (<http://www-bimas.cit.nih.gov/molbio/hla_bind/>; Parker et al. [@CR36]) and NetCTL tools (<http://www.cbs.dtu.dk/services/NetCTL/>; Larsen et al. [@CR29]). For the epitope to be included in the hit list, it must be predicted by any three of these four mentioned tools. For making the predictions of B-cell epitopes, BepiPred (<http://www.cbs.dtu.dk/services/BepiPred/>; Larsen et al. [@CR30]) and ABCPred tools (<http://www.imtech.res.in/raghava/abcpred/ABC_submission.html>; Saha and Raghava [@CR41], [@CR42]) were used. The overlapping B-cell and T-cell epitopes were identified.

Docking of the Predicted Epitopes with HLA-A\*0201 {#Sec15}
--------------------------------------------------

The predicted epitopes were docked with receptor that is HLA-A\*0201 using ClusPro (<http://cluspro.bu.edu/login.php>; Kozakov et al. [@CR27]) that is an automated protein-protein docking web server. The literature searches provided the information of conserved residues of the receptor site. The default parameters were used for docking (Comeau et al. [@CR10], [@CR11]; Kozakov et al. [@CR26]).

Results and Discussion {#Sec16}
======================

Retrieval of Proteome from NCBI {#Sec17}
-------------------------------

A total of 40 different sequenced strains of coronavirus are available at NCBI. Among them 7 strains are pathogenic to humans. Various information regarding source, host and collection of these strains are presented in Table [15.1](#Tab1){ref-type="table"} and [15.2](#Tab2){ref-type="table"}. This information can be obtained from NCBI's genome database, the Virus Pathogen Database and Analysis Resource and Genomes OnLine Database (Liolios et al. [@CR31]; Pickett et al. [@CR37]). The MERS strain is taken as seed genome as it is the most prevalent and disastrous strain among others. Its proteome consists of total 11 proteins as shown in Table [15.3](#Tab3){ref-type="table"}. The results of sequence similarity to reveal orthologs using Blastp are shown in Table [15.4](#Tab4){ref-type="table"}. The sequences with greater than 30% identity score are considered as homologs. The phylogenetic tree is depicted in Fig. [15.1](#Fig1){ref-type="fig"} and the MERS-CoV, taken as seed genome, found clustered with different Bat coronaviruses.Table 15.1Information of coronavirus strains available at NCBIS. no.Infected hostCoronavirus strainsGenome\#No of proteinsS. no.Infected hostCoronavirus strainsGenome\#No of proteins1HumanHuman coronavirus 229ENC_002645821ThrushThrush coronavirus HKU12--600NC_01154992HumanSARS coronavirusNC_0047181422MuniaMunia coronavirus HKU13--3514NC_01155093HumanHuman coronavirus OC43NC_005147923RatRat coronavirus ParkerNC_012936104HumanHuman coronavirus NL63NC_005831624BovineBovine respiratory coronavirus AH187NC_012948125HumanHuman coronavirus HKU1NC_006577825BovineBovine respiratory coronavirus bovine/US/OH-440-TC/1996NC_012949116HumanHuman enteric coronavirus strain 4408NC_0129501226BatBat coronavirus BM48--31/BGR/2008NC_01447097HumanMiddle East respiratory syndrome coronavirusNC_0198431127PorcinePorcine coronavirus HKU15NC_01699078BovineBovine coronavirusNC_0030451228White-eye birdWhite-eye coronavirus HKU16NC_01699189BatBat coronavirus (BtCoV/133/2005)NC_008315829SparrowSparrow coronavirus HKU17NC_016992810BatTylonycteris bat coronavirus HKU4NC_009019930Magpie-robinMagpie-robin coronavirus HKU18NC_016993911BatPipistrellus bat coronavirus HKU5NC_009020931Night-heronNight-heron coronavirus HKU19NC_016994812BatRousettus bat coronavirus HKU9NC_009021832WigeonWigeon coronavirus HKU20NC_0169951013BatScotophilus bat coronavirus 512NC_009657633MoorhenCommon moorhen coronavirus HKU21NC_016996914BatRhinolophus bat coronavirus HKU2NC_009988834RabbitRabbit coronavirus HKU14NC_0170831115EquineEquine coronavirusNC_0103271135BatRousettus bat coronavirus HKU10NC_018871916BatBat coronavirus 1BNC_010436736BatBat coronavirus CDPHE15/USA/2006NC_022103717BatBat coronavirus 1ANC_010437737*Erinaceus*Betacoronavirus Erinaceus/VMC/DEU/2012NC_0226431218BatMiniopterus bat coronavirus HKU8NC_010438838MinkMink coronavirus strain WD1127NC_0237601019WhaleBeluga whale coronavirus SW1NC_0106461439BatBat Hp-betacoronavirus/Zhejiang2013NC_025217920TurkeyTurkey coronavirusNC_0108001140BirdsBetacoronavirus HKU2NC_02601110 Table 15.2Detail information about seven strains of coronavirus which are pathogenic to humansS. no.Strain nameAcc. No.Source informationLengthProteinsHostCollection dateSequencing centreSequencing strategyNCBI BioProject IDCulture typeHost taxonomy IDCompletion dateGC%1.*Human coronavirus 229E*NC_002645Strain:229E27,317 nt8Vertebrates, human1/11/2001University of Wurzburg (Germany)Whole genome sequencing[14913](http://www.ncbi.nlm.nih.gov/bioproject/14913)Isolate960610/2/200638.32.*SARS coronavirus*NC_004718Isolate:Tor229,751 nt14Vertebrates, human4/14/2003[National Microbiology Laboratory, Public Health Agency of Canada](http://www.nml-lnm.gc.ca/index-eng.htm)Whole genome sequencing[15500](http://www.ncbi.nlm.nih.gov/bioproject/15500)Isolate196,29610/2/200640.83.*Human coronavirus OC43*NC_005147Strain: ATCC VR-759; isolate:OC4330,738 nt9Vertebrates, human10/29/2003[University of Leuven -- KU Leuven (Belgium](http://www.kuleuven.be/english/))Whole genome sequencing[15438](http://www.ncbi.nlm.nih.gov/bioproject/15438)Isolate960610/2/200636.84.*Human coronavirus NL63*NC_005831Strain: Amsterdam I27,553 nt6Vertebrates, human3/23/2004[University of Amsterdam (Netherlands](http://www.english.uva.nl/start.cfm))Whole genome sequencing[14960](http://www.ncbi.nlm.nih.gov/bioproject/14960)Isolate960610/2/200634.55.*Human coronavirus HKU1*NC_006577Isolate:HKU129,926 nt8Vertebrates, human12/28/2004[University of Hong Kong (Hong Kong)](http://genome.hku.hk/portal/)Whole genome sequencing[15139](http://www.ncbi.nlm.nih.gov/bioproject/15139)Isolate960610/2/200632.16.*Human enteric coronavirus strain 4408*NC_012950Strain:440830,953 nt12Vertebrates, human7/13/2009--Whole genome sequencing[39335](http://www.ncbi.nlm.nih.gov/bioproject/39335)Isolate960610/13/200937.17.Middle East respiratory syndrome coronavirusNC_019843Strain: HCoV-EMC30,119 nt11Vertebrates12/13/2012[Health Protection Agency (HPA), UK (United Kingdom)](http://www.hpa.org.uk/)Whole genome sequencing[183710](http://www.ncbi.nlm.nih.gov/bioproject/183710)Isolate960612/8/201441.2 Table 15.3Information of MERS-CoV (NC_019843.3) proteinsS. no.GeneIDStartStopLocusLocus tagProtein AccessionLengthProtein name1.1425460227913454orf1abG128_gp01YP_009047203.143911A polyprotein2.1425460227921514orf1abG128_gp01YP_009047202.170781ab polyprotein3.142545942145625517SG128_gp02YP_009047204.11353Spike glycoprotein4.142545952553225843orf3G128_gp03YP_009047205.1103NS3 protein5.142545962585226181orf4aG128_gp04YP_009047206.1109NS4A protein6.142545972609326833orf4bG128_gp05YP_009047207.1246NS4B protein7.142545982684027514orf5G128_gp06YP_009047208.1224NS5 protein8.142545992759027838EG128_gp07YP_009047209.182Envelope protein9.142546002785328512MG128_gp08YP_009047210.1219Membrane protein10.142546012856629807NG128_gp09YP_009047211.1413Nucleoprotein11.199100052876229100orf8bG128_gp10YP_009047212.1112ORF8b protein Table 15.4Results of Homology searches of the proteins of seed genome using BlastpS. no.Accession no.Protein name*SARS coronavirusHuman coronavirus OC43*Human coronavirus NL63Human coronavirus HKU1Human enteric coronavirus strain 4408Human coronavirus 229EAccession no.IdentityAccession no.IdentityAccession no.IdentityAccession no.IdentityAccession no.IdentityAccession no.Identity1YP_009047202.11ab polyproteinNP_828849.2\| orf1ab polyprotein42.89%NP_937947.2\| replicase polyprotein48.12%YP_003766.2\| replicase polyprotein45.49%YP_173236.1\| orf1ab polyprotein48.23%YP_003038518.1\| orf1ab polyprotein35.83%NP_073549.1\| replicase polyprotein33.76%NP_828850.1\| orf1a polyprotein45.94%--------YP_173236.1\| orf1ab polyprotein55.34%--------2YP_009047203.11A polyproteinNP_828850.1\| orf1a polyprotein42.62%NP_937947.2\| replicase polyprotein35.85%YP_003766.2\| replicase polyprotein 1ab33.87%YP_173236.1\| orf1ab polyprotein36.10%YP_003038519.1\| orf1a polyprotein35.82%NP_073550.1\| replicase polyprotein33.76%3YP_009047204.1\|Spike glycoprotein------------YP_173238.1\| spike glycoprotein41.28%YP_003038522.1\| spike protein37.72%NP_073551.1\| surface glycoprotein35.79%4YP_009047205.1NS3 protein------------------------5YP_009047206.1NS4A protein------------------------6YP_009047207.1NS4B protein------------------------7YP_009047208.1NS5 protein------------------------8YP_009047209.1Envelope protein------------------------9YP_009047210.1Membrane proteinNP_828855.1\| matrix protein45.45%NP_937953.1\| M protein33.81%--------YP_003038527.1\| membrane protein44.39%NP_073555.1\| membrane protein34.52%10YP_009047211.1NucleoproteinNP_828858.1\| nucleocapsid protein38.69%--------YP_173242.1\| nucleocapsid40.83%YP_003038528.1\| nucleocapsid40.83%----11YP_009047212.1ORF8b protein------------------------The accession number and identity of orthologs obtained in different strains is shown in the table Fig. 15.1Phylogenetic tree of 40 different strains of coronavirus using whole genome sequences (Alignment of genome sequences is done using ClustalW, and tree is created using NJ method from Unipro UGENE 1.15.1 bioinformatics toolkit)

Analysis of Secondary Structure {#Sec18}
-------------------------------

The results of analysis of secondary structure of the proteome using ExPASy tools are shown in the Table [15.5](#Tab5){ref-type="table"}. From the analysis of charge on the residues and pH values, it is concluded that six of the proteins are basic and positively charged unlike allergens which are acidic in nature. However, five proteins are acidic and show negative charge. The negative GRAVY score of five proteins justify them to be of hydrophilic nature with majority of the residues positioned towards the surface. For the rest of six proteins, the GRAVY score is positive; it means that these are hydrophobic proteins. The proteins with less than 40 value of instability index are quite stable than those with higher values. All the proteins are having the molecular weight less than 110 kDa except 3 (YP_009047202.1, YP_009047203.1 and YP_009047204.1). This exhibits the effectiveness of lightweight proteins as targets as they can be easily purified because of their low molecular weights. The protein YP_009047204.1 is reported as a spike glycoprotein. It is acidic with prominent negative charge, with negative GRAVY score which suggests its hydrophilicity and presence on surface. However the envelope protein YP_009047209.1 and membrane protein YP_009047210.1 are basic and hydrophobic.Table 15.5Secondary structure analysis of MERS-CoV proteinsS. noAccession no.Molecular weightTheoretical PIGRAVYAliphatic IndexInstability indexEstimated half lifeExtinction coefficientPositive chargedNegative charged1YP_009047202.1789461.26.470.01388.0334.2430978,5206476872YP_009047203.1485956.46.280.08191.5434.0730575,4153854163YP_009047204.1149,3685.7−0.07482.7136.630170,865951124YP_009047205.111137.55.39−0.02286.0225.54306085695YP_009047206.112242.86.25−0.26383.347.023027,055896YP_009047207.128,6039.74−0.22894.2351.093034,50529187YP_009047208.125280.19.260.807124.3351.43019,4101798YP_009047209.19354.27.640.795111.59333010,220549YP_009047210.124536.89.270.436104.6143.673053,525161110YP_009047211.145062.310.05−0.8665748.623047,900553311YP_009047212.112279.610.150.131113.2149.65305500117

Subcellular Localization Predictions {#Sec19}
------------------------------------

Figure [15.2](#Fig2){ref-type="fig"} depicts the subcellular localization of proteins of the seed genome, i.e. MERS-CoV. Only one protein was predicted to be localized in host cytoplasm, four in host membrane, two in both host cell membrane and endoplasmic reticulum (ER) while two in only ER, and two are left unrecognized. The known spike protein is predicted to be localized in host ER. From these results we decided to pick the proteins which are located in host membrane or were predicted to be localized in both host membrane and ER. The two are known envelop protein and membrane protein from bibliographic studies, and along with that, the known spike protein was also included in the filtered results. Out of the filtered proteins, only two (YP_009047210.1 and YP_009047208.1) contain more than two transmembrane helices, therefore filtered out. The results of transmembrane helices prediction are tabulated in Table [15.6](#Tab6){ref-type="table"}. Figure [15.3](#Fig3){ref-type="fig"} depicts the subcellular localization of proteins of all the four selected genomes using Virus-mPLoc prediction tool.Fig. 15.2Subcellular localization of seed genome proteins predicted using Virus-mPLoc Table 15.6Subcellular Localization prediction results using Virus-mPlocSubcellular localizationHuman coronavirus NL63Human coronavirus HKU1Human enteric coronavirus strain 4408Human coronavirus 229EHuman coronavirus OC43SARS coronavirusMERS coronavirusHost cell membrane. Host endoplasmic reticulumYP_003769.1--YP_003038527.1------YP_009047209.1YP_003770.1YP_009047210.1Host cell membrane. Host cytoplasmYP_003768.1Host endoplasmic reticulumYP_003767.1YP_173238.1YP_003038522.1NP_073551.1NP_937950.1NP_828851.1YP_009047204.1--YP_173241.1--NP_073554.1NP_937953.1NP_828856.1YP_009047211.1------NP_828857.1--NP_828858.1Host cell membrane--YP_173240.1YP_003038526.1NP_073552.1NP_937952.1NP_828852.2YP_009047205.1----NP_073555.1--NP_828854.1YP_009047206.1--NP_828855.1YP_009047207.1--YP_009047208.1Host cytoplasm-YP_173239.1YP_003038520.1NP_073553.1NP_937948.1NP_828853.1YP_009047212.1YP_173243.1YP_003038525.1--NP_937951.1NP_849177.1----YP_003038529.1NP_937955.1NP_828859.1Host endoplasmic reticulum. Host cytoplasmYP_003771.1YP_173237.1YP_003038521.1NP_073556.1NP_937949.1------YP_173242.1YP_003038528.1--NP_937954.1------UnrecognizedYP_003766.2YP_173236.1YP_003038518.1NP_073549.1NP_937947.2NP_828849.2YP_009047202.1----YP_003038519.1NP_073550.1--NP_828850.1YP_009047203.1YP_003038523.1--NP_849175.1--YP_003038524.1NP_849176.1 Fig. 15.3Subcellular localization of proteins of all four selected genomes predicted using Virus-mPLoc

Signal Peptides {#Sec20}
---------------

The proteins that are predicted to possess the signal peptides by Signal-BLAST web server are YP_009047204.1 and YP_009047205.1. The results of Signal-BLAST web server are tabulated in the Table [15.7](#Tab7){ref-type="table"}.Table 15.7The signal peptide prediction results for proteins of MERS coronavirus strainS. no.Accession no.Signal blast (Sensitivity)SpecificityBalanced predictionCleavage site1YP_009047202.1NoNoNoYes2YP_009047203.1NoNoNoYes3YP_009047204.1YesYesYesYes4YP_009047205.1YesYesYesYes5YP_009047206.1NoNoNoYes6YP_009047207.1NoNoNoYes7YP_009047208.1NoNoNoYes8YP_009047209.1NoNoNoNo alignment found, unable to predict9YP_009047210.1NoNoNoNo alignment found, unable to predict10YP_009047211.1NoNoNoYes11YP_009047212.1NoNoNoNo alignment found, unable to predict

Adhesion Probability {#Sec21}
--------------------

This step takes into account the concept of adhesion-based virulence. Adhesions cause pathogen recognition and initiation of inflammatory responses by the host. SPAAN predicted 2 (YP_009047204.1 and YP_009047205.1) out of 11 proteins of MERS strain as adhesive (Table [15.8](#Tab8){ref-type="table"}).Table 15.8Table illustrating the prediction results made for selecting adhesion proteins using SPAAN, BetaWrap predictions and antigenicity predictions using Vaxijen *version* 2.0S. noAccession no.Adhesion probabilityP-valueVaxijen valueTMHMM1YP_009047202.10.439813No0.4908142YP_009047203.10.442577No0.4884143YP_009047204.10.6347110.00460.484914YP_009047205.10.635586No0.422605YP_009047206.10.44212No0.328806YP_009047207.10.269269No0.497807YP_009047208.10.237608No0.336938YP_009047209.10.389879No0.511919YP_009047210.10.461965No0.5503310YP_009047211.10.690125No0.6036011YP_009047212.10.342692No0.60780The transmembrane prediction results using TMHMM are also tabulated

BetaWrap {#Sec22}
--------

Only one protein (YP_009047204.1) was predicted to contain BetaWrap motifs within it (Table [15.8](#Tab8){ref-type="table"}). Hence, it is considered virulent and might be responsible for initializing the infection in the host.

VaxiJen *2.0* {#Sec23}
-------------

A total of 9 out of 11 proteins of MERS strain were predicted antigenic (prediction values greater than 0.4). The protein with accession number YP_009047206.1 and YP_009047208.1 were among the filtered proteins, however, not predicted antigenic, therefore filtered out. As a result, only four proteins (YP_009047204.1, YP_009047205.1, YP_009047207.1 and YP_009047209.1) were kept for further analyses.

AlgPred and Allertop {#Sec24}
--------------------

None of the 11 proteins of MERS-CoV possessed any clue of allergenicity as per prediction results from AlgPred and Allertop tools; it means that no vigorous immune responses will be mounted if the epitopes from these proteins will be adopted as vaccine candidates.

Similarity with Host Proteome {#Sec25}
-----------------------------

None of the protein of MERS strain shows similarity with the proteins of host that demonstrates that the epitopes from these proteins can safely elicit the required immune response without the hazard of autoimmunity.

Epitope Mapping {#Sec26}
---------------

In total 12 different 9-mer epitopes with potential to bind to receptors of both B-cell and T-cell were predicted. The list of the predicted epitopes can be found in the Table [15.9](#Tab9){ref-type="table"} and are specific for MERS-CoV strain. All these epitopes displayed no conservancy with proteins of other human and non-human pathogenic strains.Table 15.9The results of overlapping T-cell and B-cell epitope predictions for four filtered proteinsS. noAccession noStarting position9-mer epitopeBinding energyH-bondingReceptor residues involved in H-bonding1YP_009047204.118YVDVGPDSV−854.813Lys-66, 146, His-70, Thr-73, Arg-97, Trp-147, Tyr-159,59,99, Glu-63, Asp-3110KQFANGFVV−764.69Lys-66, His-70, Glu-63,166, Thr-163, Tyr-99,159160KMGRFFNHT−849.711Lys-66, Arg-97, Tyr-159,171, Glu-166,63, Gln-155, His-70388LLSGTPPQV−713.110Lys-66,146, Arg-97, Trp-147, Tyr-159,99, Gln-155, Asp-77553WLVASGSTV−843.613Lys-66,Thr-73,163, Arg-97, Trp-147,167, Asp-77, Tyr-99, Glu-63630FVYDAYQNL−785.611Thr-73, Arg-97, Lys-146, Trp-147, Gln-155, Asp-77, Gln-155716GLVNSSLFV−887.114Tyr-59,159,99, Lys-66,146, Arg-97, Gln-155, Glu-631275ALNESYIDL−650.111Lys-66,146, Thr-73, Arg-75,97, Trp-147, Gln-155, Tyr-1592YP_009047205.118LVTASSKPL−813.99Lys-66, Arg-97, Trp-147, Gln-155, Glu-63, Tyr-159, Thr-73, Asp-773YP_009047207.1187KLHALDDVT−649.312Lys-66,146, Tyr-116, Trp-147, Glu-634YP_009047209.121VVCAITLLV−951.712Lys-66,146, Arg-97, Tyr-116,99, Trp-147,167, Thr-163, Glu-166,6327TLLVCMAFL−9167Lys-66, Trp-167, Glu-63, Tyr-159,99,Gln-155, Thr-163

Docking Analysis {#Sec27}
----------------

Docking permits to reveal the binding energy or potency of connection among epitopes and the receptor in appropriate orientation. The ClusPro docking server was used to dock the predicted 90 epitopes against HLA-A\*0201. The structure of the receptor was available from PDB and was optimized before docking to free it from the complexed self-peptide (4U6Y, Resolution 1.47 Å, Bouvier et al. [@CR4]). PEPstr (Peptide Tertiary Structure Prediction Server; Kaur et al. [@CR23]) was used to derive the tertiary structure of the predicted peptides.

Figure [15.4](#Fig4){ref-type="fig"} depicts the quaternary structure of the receptor HLA-A\*0201 with its conserved active site known to form complex with the peptides (Bouvier et al. [@CR4]). The binding energy results obtained after performing docking analysis are listed in Table [15.9](#Tab9){ref-type="table"}.Fig. 15.43D structure of receptor site of HLA-A\*0201 visualized using Swiss PDB viewer 4.10. The residues shown in globular structure are known to be conserved and form hydrogen bonds with the binding peptides

The 9-mer epitope VVCAITLLV at site 21 of protein YP_009047209.1 docked to the receptor with smallest amount of binding energy (−951.7) and 12 hydrogen bonds. The next epitope in the list was also from the same protein YP_009047209.1 at site 27, i.e. TLLVCMAFL. The predicted structure of the top 5 potent epitopes on the basis of docking energy and the snapshots of docking results are displayed in Figs. [15.5](#Fig5){ref-type="fig"}, [15.6](#Fig6){ref-type="fig"}, [15.7](#Fig7){ref-type="fig"}, [15.8](#Fig8){ref-type="fig"} and [15.9](#Fig9){ref-type="fig"}.Fig. 15.5(**a**) 3D Structure of the 9-mer epitope starting from 21(VVCAITLLV) position of protein YP_009047209.1 (**b**) Docking results of epitope "VVCAITLLV" with A chain of HLA-A\*0201 using ClusPro. (**c**) The snapshot representing the epitope docked in the pocket of molecular surface of the receptor (all the structures are visualized using Chimera 1.10.1) Fig. 15.6(**a**) 3D Structure of the 9-mer epitope starting from 27(TLLVCMAFL) position of protein YP_009047209.1. (**b**) Docking results of epitope "TLLVCMAFL" with A chain of HLA-A\*0201 using ClusPro. (**c**) The snapshot representing the epitope docked in the pocket of molecular surface of the receptor (all the structures are visualized using Chimera 1.10.1) Fig. 15.7(**a**) 3D Structure of the 9-mer epitope starting from 716(GLVNSSLFV) position of protein YP_009047204.1. (**b**) Docking results of epitope "GLVNSSLFV" with A chain of HLA-A\*0201 using ClusPro. (**c**) The snapshot representing the epitope docked in the pocket of molecular surface of the receptor (all the structures are visualized using Chimera 1.10.1) Fig. 15.8(**a**) 3D Structure of the 9-mer epitope starting from 18(YVDVGPDSV) position of protein YP_009047204.1. (**b**) Docking results of epitope "YVDVGPDSV" with A chain of HLA-A\*0201 using ClusPro. (**c**) The snapshot representing the epitope docked in the pocket of molecular surface of the receptor (all the structures are visualized using Chimera 1.10.1) Fig. 15.9(**a**) 3D Structure of the 9-mer epitope starting from 160(KMGRFFNHT) position of protein YP_009047204.1. (**b**) Docking results of epitope "KMGRFFNHT" with A chain of HLA-A\*0201 using ClusPro. (**c**) The snapshot representing the epitope docked in the pocket of molecular surface of the receptor (all the structures are visualized using Chimera 1.10.1)

The most chief restriction for developing a safe and sound vaccine against any of the virus is to identify the protective antigens. The present study is an effort of application of reverse vaccinology approach to investigate a choice of coronavirus proteomes to identify possible vaccine targets. This technique has demonstrated to be a competent way to forecast 12 different epitopes from the selected seed genome. These epitopes are from spike glycoprotein, NS3 protein, NS4B protein and envelope protein. Unfortunately none of the epitope is found conserved in other strains, and all are specific to MERS-CoV. The docking analysis studies revealed perfect binding between HLA-A\*0201 receptor and epitopes. The conserved residues of the receptor site are also involved in H-bonding with epitope residues. Further, the selected antigenic epitopes must be validated using in vitro and in vivo studies to confirm their potential as vaccine candidates.
